Kobayashi Pharmaceutical Co (TSE:4967) Construction In Progress : 円31,066 Mil (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Kobayashi Pharmaceutical Co Construction In Progress?

Kobayashi Pharmaceutical Co's quarterly construction in progress increased from Sep. 2023 (円22,083 Mil) to Dec. 2023 (円24,534 Mil) and increased from Dec. 2023 (円24,534 Mil) to Mar. 2024 (円31,066 Mil).

Kobayashi Pharmaceutical Co's annual construction in progress increased from Dec. 2021 (円2,555 Mil) to Dec. 2022 (円12,982 Mil) and increased from Dec. 2022 (円12,982 Mil) to Dec. 2023 (円24,534 Mil).

Kobayashi Pharmaceutical Co Construction In Progress Historical Data

The historical data trend for Kobayashi Pharmaceutical Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kobayashi Pharmaceutical Co Construction In Progress Chart

Kobayashi Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Construction In Progress

Get a 7-Day Free Trial

1,519.00

1,337.00

2,555.00

12,982.00

24,534.00

Kobayashi Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Construction In Progress	Get a 7-Day Free Trial															19,621.00	20,511.00	22,083.00	24,534.00	31,066.00

Kobayashi Pharmaceutical Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Kobayashi Pharmaceutical Co (TSE:4967) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kobayashi Pharmaceutical Co Ltd (TSE:4967) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

KOY:Germany

Address

KDX Kobayashi Doshomachi Building, 4-4-10 Doshomachi, Chuo-ku, Osaka, JPN, 541-0045

Website

https://www.kobayashi.co.jp

Kobayashi Pharmaceutical Co Ltd is a consumer product company focusing on niche markets. Its portfolio ranges from OTC pharmaceuticals, household products, to body warmers, and skincare. Kobayashi mainly sells its products in drugstores, convenience stores, and general merchandise stores, or GMSes. It has a geographical presence in Japan and is expanding overseas business in the U.S., China, and Southeast Asia.

Kobayashi Pharmaceutical Co (TSE:4967) Headlines

No Headlines